skip navigation

Skip Nav

Clinical Guidelines Portal

Clinical Guidelines Portal

Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents

Appendix C: Panel Roster and Financial Disclosures

Bacterial Enteric

(Last updated: September 1, 2014; last reviewed: September 1, 2014)

Bacterial Enteric Infections
Member Financial Disclosure
Company Relationship
Bowen, Anna Centers for Disease Control and Prevention Procter and Gamble Research Support
Pham, Paul Johns Hopkins University Barclay Consultant
Janssen Consultant
Maryland MADAP Consultant
Sears, Cynthia* Johns Hopkins University Clinical Infectious Diseases Other
L-2 Diagnostics Research Support
NIH Research Support
Optimer Pharmaceuticals, Inc. Advisory Board
Up-To-Date Other
Wanke, Christine Tufts University Medical School GlaxoSmithKline Research Support
Optimer Pharmaceutical DSMB
Pfizer Clinical Trial Even Adjucation
* Group lead

Note: Members were asked to disclose all relationships from 24 months prior to the updated date. The period of reporting was from September 1, 2012, through September 1, 2014.

Back to Top